Trupanion, Inc. (NASDAQ:TRUP) CEO Margaret Tooth Sells 4,000 Shares

Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) CEO Margaret Tooth sold 4,000 shares of Trupanion stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $37.17, for a total transaction of $148,680.00. Following the completion of the sale, the chief executive officer now directly owns 118,784 shares in the company, valued at approximately $4,415,201.28. This represents a 3.26 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Margaret Tooth also recently made the following trade(s):

• On Tuesday, March 4th, Margaret Tooth sold 2,294 shares of Trupanion stock. The stock was sold at an average price of $31.39, for a total transaction of $72,008.66.

Trupanion Stock Performance

Shares of NASDAQ:TRUP traded down $1.98 during trading on Friday, hitting $36.25. 443,337 shares of the company were exchanged, compared to its average volume of 646,306. Trupanion, Inc. has a 52-week low of $19.69 and a 52-week high of $57.90. The stock has a 50 day moving average of $41.03 and a 200 day moving average of $46.55. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66. The company has a market cap of $1.54 billion, a PE ratio of -157.61, a P/E/G ratio of 6.02 and a beta of 1.70.

Trupanion (NASDAQ:TRUP - Get Free Report) last issued its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.06 by ($0.02). Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The company had revenue of $337.31 million for the quarter, compared to analysts' expectations of $335.41 million. As a group, equities research analysts predict that Trupanion, Inc. will post 0.13 EPS for the current year.

Remove Ads

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on TRUP shares. Piper Sandler reduced their price objective on Trupanion from $57.00 to $52.00 and set an "overweight" rating for the company in a report on Thursday, February 20th. Stifel Nicolaus cut their price target on Trupanion from $44.00 to $41.00 and set a "hold" rating for the company in a research note on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $46.60.

Hedge Funds Weigh In On Trupanion

Large investors have recently modified their holdings of the company. Jones Financial Companies Lllp increased its holdings in Trupanion by 71.7% during the 4th quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider's stock worth $27,000 after acquiring an additional 238 shares during the period. GAMMA Investing LLC grew its position in shares of Trupanion by 18.5% during the 4th quarter. GAMMA Investing LLC now owns 1,709 shares of the financial services provider's stock valued at $82,000 after purchasing an additional 267 shares in the last quarter. Coppell Advisory Solutions LLC increased its holdings in shares of Trupanion by 58.3% in the fourth quarter. Coppell Advisory Solutions LLC now owns 1,249 shares of the financial services provider's stock worth $61,000 after purchasing an additional 460 shares during the period. SBI Securities Co. Ltd. purchased a new stake in shares of Trupanion in the fourth quarter worth $25,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Trupanion by 7.3% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,861 shares of the financial services provider's stock valued at $414,000 after buying an additional 671 shares during the period.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.